Table 1.
Group | Disease | All Recalls | True Positive Cases | Incidence | Incidence before Screening | False Positive Cases | Missed Cases | PPV |
---|---|---|---|---|---|---|---|---|
Amino acidemias | HCY | 15 | 3 | 1:330,000 | 1:265,000 | 12 | - | 20% |
MSUD | 20 | 9 | 1:110,000 | 1:265,000 | 11 | - | 45% | |
PKU | 77 | 74 2 | 1:14,000 | N/A | 3 | - | 96% | |
Carnitine disorders | CACT/CPT2 | 14 | 3 3 | 1:330,000 | N/A | 11 | 2 CPT2 6 | 21% |
CUD | 107 | 13 | 1:80,000 | N/A | 94 5 | - | 12% | |
CPT1 | 6 | 5 | 1:200,000 | N/A | 1 | - | 83% | |
Fatty acid oxidation defects | LCHAD | 14 | 13 | 1:80,000 | 1:92,000 | 1 | - | 93% |
MAD | 39 | 5 | 1:170,000 | N/A | 34 | - | 15% | |
MCAD | 67 | 59 | 1:17,000 | 1:235,000 | 8 | - | 88% | |
VLCAD | 46 | 24 | 1:42,000 | 1:1,060,000 | 22 | - | 52% | |
Organic acidurias | BKT | 2 | 2 | 1:500,000 | N/A | 0 | - | 100% |
GA1 | 31 | 9 | 1:110,000 | 1:235,000 | 22 | - | 29% | |
IVA | 18 | 6 | 1:170,000 | 1:530,000 | 12 | - | 33% | |
MMA/PA | 165 | 63 (15) 4 | 1:16,000 (1:67,000) | N/A (1:118,000) | 102 (150) | 1 PA 7 | 38% (9%) | |
TYR | 10 | 9 | 1:110,000 | N/A | 1 | - | 90% | |
Urea cycle disorders | ARG | 4 | 2 | 1:500,000 | 1:265,000 | 2 | - | 50% |
ASA 1 | 5 | 3 | 1:330,000 | N/A | 2 | 1 ASA 8 | 60% | |
CIT 1 | 25 | 9 | 1:110,000 | 1:2,120,000 | 16 | - | 36% | |
Total | 665 | 311 (263) | 1:3200 (1:3800) | N/A | 354 (402) | 4 | 47% (40%) |
1 We could not separate ASA and CIT at point of recall before 2015. 2 Three had 6-pyruvoyl-tetrahydropterin synthase deficiency. 3 One CACT and two CPT2, one of which also had MAD. 4 Four methylmalonyl-coenzyme A mutase deficiency, one cobalamin A deficiency, three cobalamin C deficiency, seven PA and 48 B12 deficiency. 5 Six were due to confirmed maternal CUD and six due to confirmed maternal carnitine-lowering medication. 6 One was from 2011, the other was from 2012. 7 From 2014. 8 From 2016.